It’s been a busy time in the ASX healthcare sector, with annual general meeting season, vaccine news and a number of company announcements.

Here’s our fortnightly wrap of all the news driving ASX health stocks.

Fifty-three companies have gained ground over past month (October 11 through November 11), five have been flat and 69 have retreated.

Code Company Price MktCap Month return Six month return Week return %Yr
1AD Adalta 0.11 $ 28,195,223.10 -28 88 10 -7
1ST 1St Group 0.036 $ 15,286,208.51 20 16 0 -43
4DX 4Dmedical 2.11 $ 356,793,398.70 -11 0 -3 0
AC8 Auscann Hlgs 0.14 $ 42,801,393.20 -7 -18 0 -48
ACR Acrux 0.17 $ 28,687,058.51 -6 26 3 -24
ACW Actinogen Medical 0.0225 $ 24,557,089.04 -15 15 7 -40
ADO Anteotech 0.083 $ 135,433,128.52 -10 295 -15 552
ADR Adherium 0.026 $ 18,320,419.62 -16 4 24 -40
AGH Althea Group 0.45 $ 111,565,524.44 -8 15 10 7
AHK Ark Mines 0.034 $ 1,778,919.95 0 0 0 0
ALC Alcidion Group 0.155 $ 153,557,578.06 15 3 24 -23
ALT Analytica 0.0025 $ 8,799,030.83 -17 25 25 -17
AMT Allegra Orthopaedics 0.15 $ 15,668,880.45 -3 36 7 7
ANP Antisense Therapeut. 0.11 $ 56,233,639.67 -15 139 11 5
APH AP Hemp 0.18 $ 9,534,473.12 -5 24 6 6
ARX Aroa Biosurgery 1.31 $ 390,097,435.00 -3 0 2 0
AT1 Atomo Diagnostics 0.325 $ 134,323,311.21 -10 -24 -2 0
ATH Alterity Therap 0.0255 $ 35,262,631.01 -49 34 -2 6
ATX Amplia Therapeutics 0.24 $ 22,025,405.00 33 173 20 205
AVE Avecho Biotech 0.014 $ 22,364,403.88 100 75 40 250
AZV Azure Healthcare 0.093 $ 26,429,572.44 3 35 -5 22
BD1 Bard1 Life Sciences 0.025 $ 59,863,259.60 -4 -4 4 -36
BIT Biotron 0.082 $ 58,962,347.89 -9 -14 -1 15
BNO Bionomics 0.115 $ 88,229,706.00 -12 177 10 11
BOT Botanix Pharma 0.105 $ 92,406,314.18 5 133 17 -5
BPH BPH Energy 0.044 $ 23,594,603.06 0 534 5 238
BWX BWX 4.11 $ 558,175,992.00 -9 9 11 1
BXN Bioxyne 0.011 $ 7,041,599.38 0 0 -8 -39
CAJ Capitol Health 0.26 $ 266,525,937.60 8 41 4 11
CAN Cann Group 0.32 $ 87,720,872.85 -24 -65 -7 -70
CDX Cardiex 0.045 $ 36,858,862.74 -20 105 5 55
CDY Cellmid 0.1 $ 12,524,686.60 -17 -46 -5 -55
CGS Cogstate 0.985 $ 166,719,230.72 41 194 -9 186
CMP Compumedics 0.47 $ 81,494,956.08 11 -10 12 -36
CP1 Cannpal Animal 0.125 $ 11,175,000.00 14 42 19 4
CPH Creso Pharma 0.034 $ 22,717,807.76 3 -46 31 -83
CTE Cryosite 0.25 $ 11,714,890.75 -2 213 2 432
CYC Cyclopharm 2.05 $ 161,351,654.55 -15 64 3 69
CYP Cynata Therapeutics 0.9 $ 98,384,163.36 -6 28 16 -31
DVL Dorsavi 0.032 $ 9,546,385.37 -20 29 7 -2
DXB Dimerix 0.265 $ 52,436,688.71 -12 -4 4 130
EXL Elixinol Global 0.175 $ 35,674,856.84 13 -46 21 -86
EYE Nova EYE Medical 0.345 $ 50,260,398.30 10 30 8 14
FFC Farmaforce 0.07 $ 9,013,968.60 0 -13 0 -36
GLH Global Health 0.41 $ 15,576,378.40 78 204 -11 173
GSS Genetic Signatures 1.74 $ 249,969,993.00 -10 -16 -6 70
GTG Genetic Technologies 0.007 $ 57,832,087.20 -13 17 0 75
HCT Holista CollTech 0.084 $ 22,303,276.05 25 -53 4 9
IBX Imagion Biosys 0.083 $ 72,025,961.61 4 337 26 344
ICR Intelicare Holdings 0.255 $ 9,463,346.57 -9 0 -9 0
ICS ICSGlobal 1.66 $ 17,890,832.30 -5 -11 0 8
IDT IDT Australia 0.185 $ 42,898,439.52 16 19 3 16
IHL Incannex Healthcare 0.083 $ 86,167,943.78 -7 63 6 32
IMC Immuron 0.235 $ 52,663,501.41 -18 187 4 68
IMM Immutep 0.28 $ 135,538,916.98 14 100 6 -5
IMU Imugene 0.072 $ 274,512,499.71 29 157 31 177
IPD Impedimed 0.092 $ 97,842,592.12 11 130 12 -36
IVX Invion 0.011 $ 60,907,465.25 10 22 10 0
JHC Japara Healthcare Lt 0.485 $ 118,925,060.96 17 -13 23 -57
JHL Jayex Healthcare 0.033 $ 7,047,705.84 -31 32 -3 -23
KZA Kazia Therapeutics 0.88 $ 110,395,481.00 10 139 13 130
LBT LBT Innovations 0.13 $ 34,649,147.40 8 13 13 -32
LCT Living Cell Tech. 0.013 $ 7,428,732.75 -13 -7 -7 -32
LSH Lifespot Health 0.072 $ 8,273,797.52 44 118 22 57
M7T Mach7 Tech 0.97 $ 224,060,543.35 -11 72 3 48
MDC Medlab Clinical 0.19 $ 51,739,999.14 -14 -16 3 -44
MDR Medadvisor 0.4 $ 97,760,389.79 -2 -30 0 8
MEB Medibio 0.009 $ 12,128,963.12 -18 32 13 -7
MEM Memphasys 0.115 $ 83,025,126.80 10 89 15 83
MMJ MMJ Group 0.125 $ 31,043,787.98 34 4 19 -34
MVF Monash IVF Group 0.76 $ 278,588,910.60 18 41 28 -19
MVP Medical Developments 6.28 $ 406,209,409.29 19 -19 14 8
MX1 Micro-X 0.245 $ 89,291,959.75 4 81 36 0
MXC Mgc Pharmaceuticals 0.022 $ 34,456,630.05 -4 -15 0 -33
NC6 Nanollose 0.067 $ 7,653,749.42 -23 109 20 3
NEU Neuren Pharmaceut. 1.2 $ 134,091,486.36 5 -29 18 -53
NOX Noxopharm 0.53 $ 110,886,016.80 31 208 13 60
NSB Neuroscientific 0.3 $ 23,573,695.20 -12 54 3 30
NTI Neurotech Intl 0.027 $ 9,687,877.01 69 286 17 93
NXS Next Science 1.16 $ 138,836,844.60 -5 -35 3 -47
NYR Nyrada Inc. 0.205 $ 15,594,938.15 5 21 3 0
OCC Orthocell 0.355 $ 64,675,434.95 -14 1 6 -31
OIL Optiscan Imaging 0.1 $ 59,673,030.00 -13 127 2 144
ONE Oneview Healthcare 0.045 $ 7,674,829.98 0 0 5 -82
ONT 1300 Smiles 6.35 $ 149,884,170.72 -6 25 0 4
OPT Opthea 2.16 $ 749,614,455.18 -29 -26 -1 -29
OSL Oncosil Medical 0.16 $ 134,314,180.48 28 52 10 2
OSP Osprey Med Inc 0.023 $ 37,336,980.13 -18 156 15 -48
OSX Osteopore 0.585 $ 44,871,735.00 4 2 6 -35
OVN Oventus Medical 0.21 $ 33,235,107.57 -14 -18 -2 -54
PAA Pharmaust 0.11 $ 34,785,291.20 -15 10 5 0
PAB Patrys 0.02 $ 29,953,466.09 6 68 -4 1
PAL Palla Pharma 0.8 $ 95,720,462.52 11 25 14 -4
PAR Paradigm Bio. 3.07 $ 668,381,462.08 5 14 12 2
PBP Probiotec 2.07 $ 149,557,740.00 17 4 20 8
PCK Painchek 0.09 $ 102,539,236.71 -4 -44 5 -63
PGC Paragon Care 0.21 $ 70,955,911.32 31 8 11 -49
PIQ Proteomics Int Lab 0.495 $ 52,452,937.50 -17 50 1 65
PNV Polynovo 2.71 $ 1,798,159,479.68 15 6 6 24
PSQ Pacific Smiles 2.02 $ 310,101,411.00 14 62 6 14
PTX Prescient 0.064 $ 39,714,286.62 -3 36 16 39
PXS Pharmaxis 0.094 $ 38,098,113.41 11 3 -10 -54
PYC PYC Therapeutics 0.18 $ 533,596,004.42 1 139 6 224
RAC Race Oncology 1.29 $ 161,983,896.25 65 289 24 928
RAP Resapp Health 0.095 $ 71,263,231.97 -14 -41 13 -68
RCE Recce Pharmaceutical 1.07 $ 188,389,824.88 -4 161 13 275
RGS Regeneus 0.12 $ 36,034,125.72 -23 71 0 46
RHT Resonance Health 0.165 $ 68,870,209.62 -6 22 6 32
RHY Rhythm Biosciences 0.265 $ 55,411,348.03 13 233 33 84
RNO Rhinomed 0.17 $ 43,147,552.44 -6 115 0 -23
RSH Respiri 0.16 $ 115,094,366.40 -32 142 3 70
S66 Star Combo 0.345 $ 47,437,810.35 3 -22 11 -27
SCU Stemcell United 0.018 $ 11,417,342.19 38 50 6 38
SDI SDI 0.79 $ 96,281,079.30 -3 7 3 -10
SOM SomnoMed 2.29 $ 181,242,899.85 -7 110 27 -6
SUD Suda Pharmaceuticals 0.039 $ 11,966,600.18 -9 0 8 -26
SVA Simavita 0.015 $ 18,461,854.56 -21 -32 -17 88
TD1 Tali Digital 0.028 $ 20,980,546.10 4 -15 0 -70
THC THC Global 0.225 $ 41,937,383.02 -4 -25 7 -38
TLX Telix Pharmaceutical 2.57 $ 667,537,693.24 40 76 20 44
UBI Universal Biosensors 0.36 $ 61,227,795.15 24 64 16 95
VBS Vectus Biosystems 0.965 $ 22,833,170.91 -2 97 2 82
VHT Volpara Health Tech 1.34 $ 334,843,473.14 -8 2 5 -30
VLS Vita Life Sciences.. 0.845 $ 45,699,807.14 -13 50 -5 32
VTI Vision Tech 0.033 $ 30,805,492.33 6 120 22 -55
ZLD Zelira Therapeutics 0.07 $ 84,157,930.59 -3 49 -7 4
ZNO Zoono Group 1.41 $ 229,875,853.34 -23 -25 -11 662

Avecho Biotechnology (ASX:AVE) has been the biggest gainer, its shares doubling from 0.7c to 1.4c after the company announced its reformulated Propofol infusion formulation had passed a critical milestone by passing a safety study in rats. Propofol, a general anaesthetic made infamous by its involvement in the death of Michael Jackson, is used for sedation in surgeries.

Avecho’s Japanese partner pulled its support last year after studies showed the reformulated Propofol wasn’t safe to use over a 24-hour period; Avecho has now optimised the formula so that it appears to be.

The company’s shares still haven’t recovered from losing a multimillion arbitration case in November 2018 against pharma giant Mylan (back when Avecho was known as Phosphagenics), but they’re up 250 per cent over the past 12 months.

Global Health (ASX:GLH) shares have gained 78 per cent over the month after the digital health record company announced a partnership with Asthma Australia involving its Lifecard consumer health platform.

Neurotech (ASX:NTI) has been the third-biggest gainer in ASX healthcare stocks over the 31-day period, with NTI shares up 69 per cent to 2.5c. The company recently pivoted to the medical cannabis space and has a new chairman, ResApp founder Brian Leedman.

Race Oncology (ASX:RAC) took the four-spot with a 65 per cent rise. Its shares are up 928 per cent over the past 12 months, by far the best performance in the healthcare sector. It got a boost earlier this month after announcing that phase 2 study data of its anti-cancer drug would be presented at the American Society for Haematology’s annual conference.

On the flip side, Alterity Therapeutics (ASX:ATH) has been the biggest loser, declining 49 per cent to 2.55c after raising $35 million at a 25 per cent discount. Those shares were issued at 3.7c, so whoever is holding them is underwater. The money will be used to fund clinical development, including two studies of possible treatment for Multiple System Astrophy (MSA).

Respiri (ASX:RSH) has declined 32 per cent this month, although its shares are still up 142 per cent for the last six months and 70 per cent for the last 12.

Healthcare self-service digital platform Jayex Healthcare (ASX:JHL) is down 31 per cent despite signing a partnership deal with MyFiziq (ASX:MYQ).